Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis

Mucosal Immunology

Volumn 1, Issue 2, 2008, Pages 131-138

  Goyette, P ^a   Lefebvre, C ^a   Ng, A ^b   Brant, S R ^c   Cho, J H ^d   Duerr, R H ^e   Silverberg, M S ^f   Taylor, K D ^g   Latiano, A ^h   Aumais, G ⁱ   Deslandres, C ^j   Jobin, G ⁱ   Annese, V ^h   Daly, M J ^b,k   Xavier, R J ^b   Rioux, J D ^a,k  

^a MONTREAL HEART INSTITUTE   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h CSS Hospital   (Italy)

ⁱ MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^j UNIVERSITY OF MONTREAL   (Canada)

^k BROAD INSTITUTE OF MIT AND HARVARD   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 1; INTERLEUKIN 17 RECEPTOR BETA; INTERLEUKIN 17 RECEPTOR DELTA; INTERLEUKIN RECEPTOR; MACROPHAGE ACTIVATING FACTOR; MACROPHAGE ACTIVATING FACTOR 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MLH1; TOLL LIKE RECEPTOR 9;

ARTICLE; CHROMOSOME 3P; CHROMOSOME MAP; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE FUNCTION; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 48349122755     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2007.15     Document Type: Article

References (58)

1. Binder, V. Genetic epidemiology in inflammatory bowel disease. Dig. Dis. 16, 351-355 (1998).
2. Orholm, M., Munkholm, P., Langholz, E., Nielsen, O.H., Sorensen, T.I. & Binder, V. Familial occurrence of inflammatory bowel disease. N. Engl. J. Med. 324, 84-88 (1991).
3. Probert, C.S., Jayanthi, V., Hughes, A.O., Thompson, J.R., Wicks, A.C. & Mayberry, J.F. Prevalence and family risk of ulcerative colitis and Crohn's disease: An epidemiological study among Europeans and south Asians in Leicestershire. Gut 34, 1547-1551 (1993).
4. Satsangi, J. et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet. 14, 199-202 (1996).
5. Hampe, J. et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am. J. Hum. Genet] 64, 808-816 (1999).
6. Cho, J. H. et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1. Proc. Natl. Acad. Sci. USA 95 7502-7507 (1998).
7. Ma, Y. et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm. Bowel Dis. 5 271-278 (1999).
8. Rioux, J. D. et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 66, 1863.-1870 (2000).
9. Duerr, R. H., Barmada, M. M., Zhang, L., Pfutzer, R. & Weeks, D.E. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am. J. Hum. Genet. 66, 1857-1862 (2000).
10. Hugot, J.P. et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379, 821-823 (1996).
11. Paavola, P. et al. Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21. Eur J. Hum. Genet. 9, 328-334 (2001).
12. Hugot, J.P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
13. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
14. Rioux, J. D. et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29 223-228 (2001).
15. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
16. Rioux, J.D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
17. Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association-maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).
18. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007).
19. Parkes, M. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 830-832 (2007).
20. Hampe, J. et al. Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut 48, 191-197 (2001).
21. Duerr, R.H. et al. Evidence for an inflammatory bowel disease locus on chromosome 3p26: Linkage, transmission/disequilibrium and partitioning of linkage. Hum. Mol. Genet. 11, 2599-2606 (2002).
22. Leonard, E.J. & Skeel, A.H. Isolation of macrophage stimulating protein (MSP) from human serum. Exp. Cell Res. 114, 117-126 (1978).
23. Leonard, E.J. & Skeel, A. A serum protein that stimulates macrophage movement, chemotaxis and spreading. Exp. Cell. Res. 102, 434-438 (1976).
24. Morrison, A.C., Wilson, C.B., Ray, M. & Correll, P.H. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J. Immunol. 172, 1825-1832 (2004).
25. Chen, Y.Q., Fisher, J.H. & Wang, M.H. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (NOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of NOS expression. J. Immunol. 161, 4950-4959 (1998).
26. Zhou, Y.Q., Chen, Y.Q., Fisher, J.H. & Wang, M.H. Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J. Biol. Chem. 277, 38104-38110 (2002).
27. Liu, Q.P., Fruit, K., Ward, J. & Correll, P.H. Negative regulation of macrophage activation in response to IFN-gamma arid lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 163, 6606-6613 (1999).
28. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
29. Han, S., Stuart, L.A. & Degen, S.J. Characterization of the DNF15S2 locus on human chromosome 3: Identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30, 9768-9780 (1991).
30. Yoshimura, T., Yuhki, N., Wang, M.H., Skeel, A. & Leonard, E.J. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem. 268, 15461-15468 (1993).
31. Wang, M.H., Gonias, S.L., Skeel, A., Wolf, B.B., Yoshimura, T. & Leonard, E.J. Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein family. J. Biol. Chem. 269, 13806-13810 (1994).
32. Wang, M.H., Skeel, A. & Leonard, E.J. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J. Clin. Invest. 97, 720-727 (1996).
33. Iwama, A. et al. Terminal differentiation of murine resident peritoned macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood 86, 3394-3403 (1995).
34. Waltz, S.E. et al. Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J. Clin. Invest. 108, 567-576 (2001).
35. Correll, P.H., Iwama, A., Tondat, S., Mayrhofer, G., Suda, T. & Bernstein, A. Deregulated inflammatory response in mice lacking the STK/ RON receptor tyrosine kinase. Genes Funct. 1, 69-83 (1997).
36. Carafoli, F., Chirgadze, D.Y., Blundell, T. L. & Gherardi, E. Crystal structure of the beta-chain of human hepatocyte growth factor-like/ macrophage stimulating protein. FEBS J. 272, 5799-5807 (2005).
37. Danilkovitch, A., Miller, M. & Leonard, E.J. Interaction of macrophage-stimulating protein with its receptor. Residues critical for beta chain binding and evidence for independent alpha chain binding. J. Biol. Chem. 274, 29937-29943 (1999).
38. Kirchhofer, D. et al. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling. J. Biol. Chem. 279, 39915-39924 (2004).
39. Stamos, J., Lazarus, R.A., Yao, X., Kirchhofer, D. & Wiesmann, C. Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J. 23, 2325-2335 (2004).
40. Raelson, J.V. et al. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc. Natl. Acad. Sci. USA 104, 14747-14752 (2007).
41. Schreiber, S., Nikolaus, S. & Hampe, J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42, 477-484 (1998).
42. Kimura, H. et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig. Dis. Sci. 42, 1047-1054 (1997).
43. Omata, F., Birkenbach, M., Matsuzaki, S., Christ, A.D. & Blumberg, R.S. The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease. Inflamm. Bowel. Dis. 7, 215-220 (2001).
44. Smith, P.D., Ochsenbauer-Jambor, C. & Smythies, LE. Intestinal macrophages: Unique effector cells of the innate immune system. Immunol. Rev. 206, 149-159 (2005).
45. Smythies, L.E. et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115, 66-75 (2005).
46. Takeda, K. et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neurtrophils. Immunity 10, 30-49 (1999).
47. Fuss, I.J. et al. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12, 9-15 (2006).
48. Becker, C. et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112, 693-706 (2003).
49. Hue, S. et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203, 2473-2483 (2006).
50. Kullberg, M.C. et al. IL-23 plays a key role in Helicobacter hepaticus induced T cell-dependent colitis. J. Exp. Med. 203 2485-2494 (2006).
51. Tello-Ruiz, M. K. et al. Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur. J. Hum. Genet. 14, 780-790 (2006).
52. van Bodegraven, A.A. et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 131, 1768-1774 (2006).
53. De Jager, P.L. et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun. 8 387-397 (2007).
54. Lennard-Jones, J.E. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. 170 (Suppl.), 2-6 (1989)discussion 16-9.
55. Podolsky, D.K. Inflammatory bowel disease (1). N. Engl. J. Med. 325, 928-937 (1991).
56. de Bakker, P.I., Yelensky, R., Pe'er, I., Gabriel, S.B., Daly, M.J. & Altshuler, D. Efficiency and power in genetic association studies. Nat. Genet. 37, 1217-1223 (2005).
57. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
58. DeLano, W.L. The PyMOL Molecular Graphics System (DeLano Scientific, Palo Alto, CA, 2002).